Skip to main content
Made possible by:
FirstWord
Share
Journal Club: All Recent News
Sandoz receives positive CHMP opinion for proposed biosimilar infliximab
(Mar 23 2018)
Read Article
Amgen And Allergan Receive Positive CHMP Opinion For ABP 980 (Biosimilar Herceptin) For The Treatment Of Three Types Of Cancer
(Mar 23 2018)
Read Article
Nippon Kayaku Receives Manufacture and Marketing Approval in Japan for Biosimilar of Trastuzumab Monoclonal Antibody
(Mar 23 2018)
Read Article
Trump Policy Change Is a Win for Drugmakers
(Mar 22 2018)
Read Article
Britain's use of copycat biotech drugs takes off while US lags
(Mar 21 2018)
Read Article
Mundipharma expands biosimilar portfolio with exclusive partnership deal across seven European countries for trastuzumab biosimilar, Herzuma
(Mar 20 2018)
Read Article
Biocon Sees Approvals Unlocking $1 Billion Biosimilar Business
(Mar 20 2018)
Read Article
Wyoming Governor Mead Signs Bill Facilitating Patient Access to Interchangeable Biologic Medicines
(Mar 18 2018)
Read Article
Allergan CEO: We Are Looking at All Options to Create Shareholder Value
(Mar 15 2018)
Read Article
Roche CEO says new drugs will offset biosimilar incursions
(Mar 13 2018)
Read Article
ViewPoints: Coherus steps back into the race for Neulasta biosimilar
(Mar 12 2018)
Read Article
The First Biosimilar Monoclonal Antibody In Oncology, Redditux (Rituximab Biosimilar) Ready For Launch In Turkey
(Mar 9 2018)
Read Article
Charles River Laboratories Makes Expansions to Global Biologics Infrastructure
(Mar 8 2018)
Read Article
GC Pharma gets Korean approval for Lantus biosimilar
(Mar 8 2018)
Read Article
CEO Albrecht to modernize STADA – Biosimilars to focus on oncology, CNS, diabetes and ophthalmology
(Mar 8 2018)
Read Article
Launch of first breast cancer biosimilar in the UK
(Mar 8 2018)
Read Article
Celltrion reshuffles top executives for overseas push
(Mar 7 2018)
Read Article
Capturing the Benefits of Competition for Patients
(Mar 7 2018)
Read Article
Cancer Chemotherapy and Pharmacology has published comparative data of rituximab biosimilar RTXM83R in lymphoma patients
(Mar 6 2018)
Read Article
ViewPoints: European payers gear up for 2018's biosimilar windfall
(Mar 6 2018)
Read Article
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »